Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

EVG staining is a valuable, simple, and cost-effective method for diagnosing various skin conditions in dermatopathology.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Use finasteride, dutasteride, and minoxidil for hair loss treatment.

Good preoperative assessment is crucial for safe and effective eyelid and brow cosmetic surgery.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

It's unclear which molecules best characterize dry skin due to inconsistent findings.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Finasteride improves surrounding scalp hair and increases hair density after hair transplant.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Low prolactin in young women may increase heart and metabolism risks.

Ketoconazole shampoo with finasteride improves hair density in men with hair loss.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Finasteride improves surrounding scalp hair and increases hair density after hair transplant.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.